Bioactivity:

BMS-279700 is a potent oral activity inhibitor that is part of a new family of aniline 5-azimidazolaquoxaline analogs and has excellent anti-inflammatory activity in vivo, as well as in vitro activity against p56LCK and T cell proliferation, blocking the

CAS nr:

240814-54-4

Purity:

98%

Molecular Weight:

407,9

SMILES:

C[C@H]1CN(C2=CC=C3N=C(NC4=C(C)C=CC=C4Cl)C5=CN=CN5C3=N2)CCN1

Formula:

C21H22ClN7

Pathway:

Target: